EWTX Stock Price
Edgewise Therapeutics, Inc.
EWTX stock price is $37.02 (+2.04% on the day), giving Edgewise Therapeutics, Inc. a market cap of $3.94B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
EWTX Stock Overview
- Price
- $37.02
- Previous close
- $36.28
- Open
- $35.93
- Market cap
- $3.94B
- P/E ratio
- -23.5
- 52-week range
- $14.25 - $48.51
- 1-year price target
- $52.62
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 41
About Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EWTX | $37.02 | +2.0% | 1.34M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Edgewise Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW